Cargando…
A review of neurotoxicities associated with immunotherapy and a framework for evaluation
Immuno-oncology agents, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T (CAR-T) cell therapies, are increasing in use for a growing list of oncologic indications. While harnessing the immune system against cancer cells has a potent anti-tumor effect, it can also cause w...
Autores principales: | Burton, Leeann B, Eskian, Mahsa, Guidon, Amanda C, Reynolds, Kerry L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633791/ https://www.ncbi.nlm.nih.gov/pubmed/34859238 http://dx.doi.org/10.1093/noajnl/vdab107 |
Ejemplares similares
-
Management of NSAID-Associated Upper GI Disorders Using AMCP’s Framework for Quality Drug Therapy
por: Cryer, Byron, et al.
Publicado: (2005) -
Immunotherapy Associated Neurotoxicity in Pediatric Oncology
por: Shalabi, Haneen, et al.
Publicado: (2022) -
Development of a framework to guide research into policies promoting physical activity and healthy diets in the European context: the system-based Policy Evaluation Network (PEN) framework
por: Kamphuis, Carlijn B M, et al.
Publicado: (2022) -
Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
por: Diaby, Vakaramoko, et al.
Publicado: (2021) -
Neurotoxicity of novel cancer immunotherapies
por: Willis, M. D., et al.
Publicado: (2019)